S. GASTALDI

Two series of ()-2-phenyl-1-(quinolizidin-1α-yl)benzimidazoles, 12A–26A, and ()-2-phenyl-1- (quinolizidin-1β-yl)benzimidazoles, 12B–26B, were prepared and tested for the inhibition of human platelets aggregation induced by ADP, collagen, and adrenaline. All epimers A, i.e., 12A–26A, were devoid of any activity against the three agonists, while...